Effect of alcohol consumption on endothelial function in men with coronary artery disease

Atherosclerosis

Volumn 165, Issue 1, 2002, Pages 145-152

  Teragawa, Hiroki ^a   Fukuda, Yukihiro ^a   Matsuda, Keiji ^a   Higashi, Yukihito ^a   Yamagata, Togo ^a   Matsuura, Hideo ^a   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Brachial artery; Endothelium; Hyperemia; Vasodilation

Indexed keywords

ALCOHOL; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; GLYCERYL TRINITRATE; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTERY DIAMETER; ARTICLE; BRACHIAL ARTERY; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; DRINKING; ECHOGRAPHY; ENDOTHELIUM; HUMAN; HYPERURICEMIA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; RISK FACTOR; VASODILATATION;

AGED; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; BLOOD CHEMICAL ANALYSIS; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NITROGLYCERIN; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; REGIONAL BLOOD FLOW; REGRESSION ANALYSIS; ULTRASONOGRAPHY, DOPPLER; VASODILATION;

EID: 0036841889     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00193-4     Document Type: Article

References (51)

1. Muntwyler J., Hennekens C.H., Buring J.E., Gaziano J.M. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet. 352:1998;1882-1885.
2. de Vreede-Swagemakers J.J., Gorgels A.P., Weijenberg M.P., Dubois-Arbouw W.I., Golombeck B., van Ree J.W., Knottnerus A., Wellens H.J. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease. J. Clin. Epidemiol. 52:1999;601-607.
3. Cooper H.A., Exner D.V., Domanski M.J. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. J. Am. Coll. Cardiol. 35:2000;1753-1759.
4. Klatsky A.L., Armstrong M.A., Friedman G.D. Relations of alcoholic beverage use to subsequent coronary artery disease hospitalization. Am. J. Cardiol. 58:1986;710-714.
5. Rimm E.B., Giovannucci E.L., Willett W.C., Colditz G.A., Ascherio A., Rosner B., Stampfer M.J. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 338:1991;464-468.
6. Doll R., Peto R., Hall E., Wheatley K., Gray R. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. Br. Med. J. 309:1994;911-918.
7. Thun M.J., Peto R., Lopez A.D., Monaco J.H., Henley S.J., Heath Jr C.W., Doll R. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N. Engl. J. Med. 337:1997;1705-1714.
8. Ajani U.A., Gaziano J.M., Lotufo P.A., Liu S., Hennekens C.H., Buring J.E., Manson J.E. Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation. 102:2000;500-505.
9. Regan T.J. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation. 102:2000;487-488.
10. Gaziano J.M., Gaziano T.A., Glynn R.J., Sesso H.D., Ajani U.A., Stampfer M.J., Manson J.E., Hennekens C.H., Buring J.E. Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J. Am. Coll. Cardiol. 35:2000;96-105.
11. Jamrozik K., Broadhurst R.J., Forbes S., Hankey G.J., Anderson C.S. Predictors of death and vascular events in the elderly: the Perth Community Stroke Study. Stroke. 31:2000;863-868.
12. Gottrand F., Beghin L., Duhal N., Lacroix B., Bonte J.P., Fruchart J.C., Luc G. Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII. Eur. J. Clin. Invest. 29:1999;387-394.
13. Rimm E.B., Williams P., Fosher K., Criqui M., Stampfer M.J. Moderate alcohol intake and lower risk of coronary heart disease: meta- analysis of effects on lipids and haemostatic factors. Br. Med. J. 319:1999;1523-1528.
14. Pellegrini N., Pareti F.I., Stabile F., Brusamolino A., Simonetti P. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. Eur. J. Clin. Nutr. 50:1996;209-213.
15. Dimmitt S.B., Rakic V., Puddey I.B., Baker R., Oostryck R., Adams M.J., Chesterman C.N., Burke V., Beilin L.J. The effects of alcohol on coagulation and fibrinolytic factors: a controlled trial. Blood Coagul. Fibrinolysis. 9:1998;39-45.
16. Rimm E.B., Chan J., Stampfer M.J., Colditz G.A., Willett W.C. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. Br. Med. J. 310:1995;555-559.
17. Kiechl S., Willeit J., Poewe W., Egger G., Oberhollenzer F., Muggeo M., Bonora E. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). Br. Med. J. 313:1996;1040-1044.
18. Imhof A., Froehlich M., Brenner H., Boeing H., Pepys M.B., Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet. 357:2001;763-767.
19. Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes Jr D.R., Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 101:2000;948-954.
20. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long- term outcome of coronary heart disease. Circulation. 101:2000;1899-1906.
21. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., Lloyd J.K., Deanfield J.E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
22. Shaper A.G., Wannamethee S.G. Alcohol intake and mortality in middle aged men with diagnosed coronary heart disease. Heart. 83:2000;394-399.
23. Valimaki M., Laitinen K., Ylikahri R., Ehnholm C., Jauhiainen M., Bard J.M., Fruchart J.C., Taskinen M.R. The effect of moderate alcohol intake on serum apolipoprotein A-I- containing lipoproteins and lipoprotein (a). Metabolism. 40:1991;1168-1172.
24. Gorinstein S., Zemser M., Lichman I., Berebi A., Kleipfish A., Libman I., Trakhtenberg S., Caspi A. Moderate beer consumption and the blood coagulation in patients with coronary artery disease. J. Intern. Med. 241:1997;47-51.
25. Margaglione M., Cappucci G., Colaizzo D., Pirro L., Vecchione G., Grandone E., Di Minno G. Fibrinogen plasma levels in an apparently healthy general population - relation to environmental and genetic determinants. Thromb. Haemost. 80:1998;805-810.
26. Yarnell J.W., Sweetnam P.M., Rumley A., Lowe G.D. Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study. Arterioscler. Thromb. Vasc. Biol. 20:2000;271-279.
27. Stampfer M.J., Sacks F.M., Salvini S., Willett W.C., Hennekens C.H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N. Engl. J. Med. 325:1991;373-381.
28. Wilson P.W. Established risk factors and coronary artery disease: the Framingham Study. Am. J. Hypertens. 7:1994;7S-12S.
29. Haffner S.M. Epidemiology of insulin resistance and its relation to coronary artery disease. Am. J. Cardiol. 84:1999;11J-14J.
30. Anderson J.L., Carlquist J.F., Muhlestein J.B., Horne B.D., Elmer S.P. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J. Am. Coll. Cardiol. 32:1998;35-41.
31. Emeis J.J., Cohen L.H. Another view of hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors and the fibrinolytic system. Am. J. Cardiol. 80:1997;977-978.
32. Strandberg T.E., Vanhanen H., Tikkanen M.J. Associations between change in C-reactive protein and serum lipids during statin treatment. Ann. Med. 32:2000;579-583.
33. Ikonomidis I., Andreotti F., Economou E., Stefanadis C., Toutouzas P., Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation. 100:1999;793-798.
34. Feldman M., Jialal I., Devaraj S., Cryer B. Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. J. Am. Coll. Cardiol. 37:2001;2036-2041.
35. Venkov C.D., Myers P.R., Tanner M.A., Su M., Vaughan D.E. Ethanol increases endothelial nitric oxide production through modulation of nitric oxide synthase expression. Thromb. Haemost. 81:1999;638-642.
36. Davda R.K., Chandler L.J., Crews F.T., Guzman N.J. Ethanol enhances the endothelial nitric oxide synthase response to agonists. Hypertension. 21:1993;939-943.
37. Stein J.H., Keevil J.G., Wiebe D.A., Aeschlimann S., Folts J.D. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation. 100:1999;1050-1055.
38. Maiorano G., Bartolomucci F., Contursi V., Minenna F.S., Di Mise R., Palasciano A., Allegrini B., Amoruso M., Kozakova M. Noninvasive detection of vascular dysfunction in alcoholic patients. Am. J. Hypertens. 12:1999;137-144.
39. Agewall S., Wright S., Doughty R.N., Whalley G.A., Duxbury M., Sharpe N. Does a glass of red wine improve endothelial function? [see comments]. Eur. Heart. J. 21:2000;74-78.
40. Redmond E.M., Sitzmann J.V., Cahill P.A. Potential mechanisms for cardiovascular protective effect of ethanol. Acta. Pharmacol. Sin. 21:2000;385-390.
41. Matsuo S., Nakamura Y., Takahashi M., Ouchi Y., Hosoda K., Nozawa M., Kinoshita M. Effect of red wine and ethanol on production of nitric oxide in healthy subjects. Am. J. Cardiol. 87:(A6):2001;1029-1031.
42. Foody J.M., Cole C.R., Blackstone E.H., Lauer M.S. A propensity analysis of cigarette smoking and mortality with consideration of the effects of alcohol. Am. J. Cardiol. 87:2001;706-711.
43. Handa K., Sasaki J., Saku K., Kono S., Arakawa K. Alcohol consumption, serum lipids and severity of angiographically determined coronary artery disease. Am. J. Cardiol. 65:1990;287-289.
44. Liu Y., Tanaka H., Sasazuki S., et al. Alcohol consumption and severity of angiographically determined coronary artery disease in Japanese men and women. Atherosclerosis. 156:2001;177-183.
45. Solomon C.G., Hu F.B., Stampfer M.J., Colditz G.A., Speizer F.E., Rimm E.B., Willett W.C., Manson J.E. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation. 102:2000;494-499.
46. Hijmering M.L., Stroes E.S., Pasterkamp G., Sierevogel M., Banga J.D., Rabelink T.J. Variability of flow mediated dilation: consequences for clinical application. Atherosclerosis. 157:2001;369-373.
47. Matsuguchi T., Araki H., Anan T., Hayata N., Nakagaki O., Takeshita A., Nakamura M. Provocation of variant angina by alcohol ingestion. Eur. Heart. J. 5:1984;906-912.
48. Kugiyama K., Yasue H., Okumura K. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation. 94:1996;266-272.
49. Gill J.S., Shipley M.J., Tsementzis S.A., Hornby R.S., Gill S.K., Hitchcock E.R., Beevers D.G. Alcohol consumption - a risk factor for hemorrhagic and non-hemorrhagic stroke. Am. J. Med. 90:1991;489-497.
50. de Lorimier A.A. Alcohol, wine, and health. Am. J. Surg. 180:2000;357-361.
51. Fauchier L., Babuty D., Poret P., Casset-Senon D., Autret M.L., Cosnay P., Fauchier J.P. Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy. Eur. Heart. J. 21:2000;306-314.